A digital platform for understanding genetic risks of heart diseases
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
This study tests whether giving people information about their genetic risk for heart disease can help them make better health choices and improve their lifestyles.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Scripps Translational Science Institute Academic / other |
| Locations | 1 site (La Jolla, California) |
| Trial ID | NCT03277365 on ClinicalTrials.gov |
What this trial studies
This study aims to explore how genetic risk factors influence health decisions and lifestyle choices related to heart diseases, particularly coronary artery disease (CAD). Participants will receive a genetic risk score based on their 23andMe data, which ranks their genetic risk compared to global populations. By understanding their genetic predisposition, individuals may be better equipped to make informed health decisions. The study focuses on the interplay between genetic risk and controllable health behaviors.
Who should consider this trial
Good fit: Ideal candidates are customers of 23andMe who are willing to share their genetic data and use an Apple mobile device.
Not a fit: Patients under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this could empower patients to make informed lifestyle choices to mitigate their genetic risk for heart diseases.
How similar studies have performed: Other studies have shown success in using genetic risk scores to inform health decisions, making this approach promising but not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Customer of 23andMe willing to share their 23andMe data * User of Apple mobile device Exclusion Criteria: * Under 18 years old
Where this trial is running
La Jolla, California
- Scripps Translational Science Institute — La Jolla, California, United States (Recruiting)
Study contacts
- Study coordinator: Jennifer Wagner, RN
- Email: generank@scripps.edu
- Phone: 858-784-2028
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.